During the past decade, Hospital Santa María del Rosell conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Santa María del Rosell" are "Acute Lymphoblastic Leukemia" (3 trials), "Multiple Myeloma" (2 trials), "Acute Lymphoblastic Leukemia Ph Positive" (1 trials), "Acute Myeloblastic Leukaemia" (1 trials) and "Acute Promyelocytic Leukemia" (1 trials). Many other conditions were trialed in "Hospital Santa María del Rosell" in a lesser frequency.

Most popular intervention types in "Hospital Santa María del Rosell" are "Drug" (10 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARA-C" (2 trials), "Cyclophosphamide" (2 trials), "Daunorubicin" (2 trials), "Dexamethasone" (2 trials) and "Mercaptopurine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Santa María del Rosell" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Santa María del Rosell". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital Santa María del Rosell, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Santa María del Rosell, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 0 trials that are defined as “Not Applicable".